FHIR Cross-Version Extensions package for FHIR R4B from FHIR R5
0.0.1-snapshot-2 - informative
FHIR Cross-Version Extensions package for FHIR R4B from FHIR R5
0.0.1-snapshot-2 - informative
FHIR Cross-Version Extensions package for FHIR R4B from FHIR R5 - Version 0.0.1-snapshot-2. See the Directory of published versions
| Official URL: http://hl7.org/fhir/5.0/ValueSet/R5-v2-0227-for-R4B | Version: 0.0.1-snapshot-2 | |||
| Standards status: Informative | Maturity Level: 0 | Computable Name: R5_v2_0227_for_R4B | ||
| This cross-version ValueSet represents concepts from http://terminology.hl7.org/ValueSet/v2-0227 | 2.0.0 for use in FHIR R4B. Concepts not present here have direct equivalent mappings crossing all versions from R5 to R4B. |
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
http://terminology.hl7.org/CodeSystem/v2-0227 version 2.ext.0| Code | Display |
| AB | Abbott Laboratories |
| AD | Adams Laboratories, Inc. |
| ALP | Alpha Therapeutic Corporation |
| AR | Armour |
| AVB | Aventis Behring L.L.C. |
| AVI | Aviron |
| BA | Baxter Healthcare Corporation |
| BAH | Baxter Healthcare Corporation |
| BAY | Bayer Corporation |
| BP | Berna Products |
| BPC | Berna Products Corporation |
| MIP | Bioport Corporation |
| CNJ | Cangene Corporation |
| CMP | Celltech Medeva Pharmaceuticals |
| CEN | Centeon L.L.C. |
| CHI | Chiron Corporation |
| CON | Connaught |
| DVC | DynPort Vaccine Company, LLC |
| EVN | Evans Medical Limited |
| GEO | GeoVax Labs, Inc. |
| SKB | GlaxoSmithKline |
| GRE | Greer Laboratories, Inc. |
| IAG | Immuno International AG |
| IUS | Immuno-U.S., Inc. |
| KGC | Korea Green Cross Corporation |
| LED | Lederle |
| MBL | Massachusetts Biologic Laboratories |
| MA | Massachusetts Public Health Biologic Laboratories |
| MED | MedImmune, Inc. |
| MSD | Merck & Co., Inc. |
| IM | Merieux |
| MIL | Miles |
| NAB | NABI |
| NYB | New York Blood Center |
| NAV | North American Vaccine, Inc. |
| NOV | Novartis Pharmaceutical Corporation |
| NVX | Novavax, Inc. |
| OTC | Organon Teknika Corporation |
| ORT | Ortho-Clinical Diagnostics |
| PD | Parkedale Pharmaceuticals |
| PWJ | PowderJect Pharmaceuticals |
| PRX | Praxis Biologics |
| PMC | sanofi pasteur |
| JPN | The Research Foundation for Microbial Diseases of Osaka University |
| SCL | Sclavo, Inc. |
| SOL | Solvay Pharmaceuticals |
| SI | Swiss Serum and Vaccine Inst. |
| TAL | Talecris Biotherapeutics |
| USA | United States Army Medical Research and Material Command |
| VXG | VaxGen |
| WA | Wyeth-Ayerst |
| WAL | Wyeth-Ayerst |
| ZLB | ZLB Behring |
| OTH | Other manufacturer |
| UNK | Unknown manufacturer |
This value set expansion contains 55 concepts.
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2025+ FHIR Infrastructure. Package hl7.fhir.uv.xver-r5.r4b#0.0.1-snapshot-2 based on FHIR 4.3.0. Generated 2025-09-13
Links: Table of Contents |
QA Report
| Version History |
|
History